HDFC Mutual Fund Boosts Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has significantly increased its exposure to the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This strategic move comes via an open market transaction involving shares sold by the company's co-founder, Sunil Sachdeva.

Strategic Acquisition via Open Market Transaction

In a significant block deal reported on the BSE, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. This transaction, valued at approximately ₹130 crore, represents a 0.37 per cent stake in the healthcare giant.

This latest acquisition follows a similar trend from the previous month, where the fund house had already purchased 10 lakh shares from Sunil Sachdeva for over ₹122 crore. The repeated interest from one of India's largest mutual fund houses signals strong institutional confidence in the long-term growth trajectory of the Medanta brand.

Stake Dilution by Co-founder Sunil Sachdeva

The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. According to regulatory filings, Sachdeva held a 10.79 per cent stake in Global Health, amounting to 2.90 crore equity shares, as of the end of the March quarter. While the sale marks a reduction in his personal holding, the transaction is being viewed through the lens of institutional accumulation by major players like HDFC MF.

Following the news, shares of Global Health witnessed slight volatility, closing at ₹1,311.35 apiece on the BSE, reflecting a marginal slip of 0.41 per cent.

Robust Financial Performance Drives Investor Interest

The institutional appetite for Global Health is likely underpinned by the company's stellar financial performance. For the fourth quarter ended March 31, 2026, Global Health reported a significant surge in its bottom line.

Key financial highlights from the Q4 report include:

  • Profit After Tax (PAT): The company reported a 39.7 per cent increase in PAT, reaching ₹141.7 crore, compared to ₹101.4 crore in the same quarter of the previous fiscal year.
  • Revenue Growth: Revenue from operations climbed to ₹1,159 crore, up from ₹931.3 crore in the corresponding period last year.

These numbers demonstrate the company's ability to scale operations and improve profitability, making it an attractive target for large-scale institutional investors looking for exposure to India's expanding healthcare infrastructure.

Key Takeaways

  • Increased Institutional Holding: HDFC Mutual Fund has acquired an additional 0.37% stake in Global Health for ₹130 crore, marking its second major purchase from co-founder Sunil Sachdeva in two months.
  • Strong Financial Momentum: The investment follows a period of robust growth, with Global Health reporting a nearly 40% jump in quarterly profit to ₹141.7 crore.
  • Market Sentiment: The high-value transaction at ₹1,300 per share underscores strong institutional conviction in the Medanta brand's operational efficiency and revenue scalability.